Gustave Roussy immune score predicts survival outcome of patients with metastatic urothelial carcinoma treated with pembrolizumab: A multicenter study of 321 patients (YUSHIMA study)

被引：0
|
作者：
Tanabe, K. [1 ]
Shuichiro, K. [1 ]
Katsushi, N. [2 ]
Junji, Y. [3 ]
Yukihiro, O. [4 ]
Tetsuo, O. [5 ]
Ryoji, T. [6 ]
Akira, N. [1 ]
Masataka, Y. [7 ]
Tetsuro, T. [8 ]
Kazutaka, S. [9 ]
Yasuyuki, S. [10 ]
Fumitaka, K. [11 ]
Yukio, K. [12 ]
Hajime, T. [13 ]
Soichiro, Y. [13 ]
Yasuhisa, F. [13 ]
机构：
[1] Saitama Red Cross Hosp, Dept Urol, Saitama, Japan
[2] Kohnodai Hosp, Dept Urol, Chiba, Japan
[3] Canc Inst Hosp, Dept Urol, Tokyo, Japan
[4] Japanese Red Cross Omori Hosp, Dept Urol, Tokyo, Japan
[5] JA Toride Med Ctr, Dept Urol, Ibaraki, Japan
[6] Tokyo Metropolitan Otsuka Hosp, Dept Urol, Tokyo, Japan
[7] Tokyo Metropolitan Tama Nambu Chiiki Hosp, Dept Urol, Tokyo, Japan
[8] Showa Gen Hosp, Dept Urol, Tokyo, Japan
[9] Dokkyo Med Univ Saitama Med Ctr, Dept Urol, Saitama, Japan
[10] Tsuchiura Kyodo Gen Hosp, Dept Urol, Ibaraki, Japan
[11] Komagome Hosp, Dept Urol, Tokyo Metropolitan Canc & Infect Dis Ctr, Tokyo, Japan
[12] Saitama Prefectural Canc Ctr, Dept Urol, Saitama, Japan
[13] Tokyo Med & Dent Univ, Dept Urol, Tokyo, Japan
来源：
EUROPEAN UROLOGY | 2024年 / 85卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
A0752
引用
收藏
页码：S1729 / S1730
页数：2
相关论文
共 50 条
  • [1] GUSTAVE ROUSSY IMMUNE SCORE PREDICTS SURVIVAL OUTCOME OF PATIENTS WITH METASTATIC UROTHELIAL CARCINOMA TREATED WITH PEMBROLIZUMAB: A MULTICENTER STUDY OF 321 PATIENTS (YUSHIMA STUDY)
    Tanabe, Kenji
    Kobayashi, Shuichiro
    Nagahama, Katsushi
    Yonese, Junji
    Otsuka, Yukihiro
    Okuno, Tetsuo
    Takazawa, Ryoji
    Noro, Akira
    Yano, Masataka
    Tsukamoto, Tetsuro
    Saito, Kazutaka
    Sakai, Yasuyuki
    Koga, Fumitaka
    Kageyama, Yukio
    Tanaka, Hajime
    Yoshida, Soichiro
    Fujii, Yasuhisa
    JOURNAL OF UROLOGY, 2024, 211 (05): : E864 - E865
  • [2] Gustave Roussy Immune score as a prognostic biomarker in patients with platinum-refractory metastatic urothelial carcinoma treated with pembrolizumab: YUSHIMA study
    Tanabe, Kenji
    Kobayashi, Shuichiro
    Maezawa, Yuya
    Ishihara, Kensaku
    Inoue, Naoki
    Izumi, Keita
    Fujiwara, Motohiro
    Toide, Masahiro
    Yamamoto, Takanobu
    Uehara, Sho
    Araki, Saori
    Inoue, Masaharu
    Takazawa, Ryoji
    Numao, Noboru
    Ohtsuka, Yukihiro
    Tanaka, Hajime
    Yoshida, Soichiro
    Fujii, Yasuhisa
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2024, 29 (09) : 1302 - 1310
  • [3] Impact of antacids on the prognosis of patients with metastatic urothelial carcinoma treated with pembrolizumab: A retrospective multicenter study
    Sekito, T.
    Katayama, S.
    Iwata, T.
    Kawada, T.
    Tominaga, Y.
    Sadahira, T.
    Nishimura, S.
    Bekku, K.
    Edamura, K.
    Kobayashi, T.
    Kobayashi, Y.
    Araki, M.
    EUROPEAN UROLOGY, 2024, 85 : S1734 - S1735
  • [4] Effect of Antacids on the Survival of Patients With Metastatic Urothelial Carcinoma Treated With Pembrolizumab
    Sekito, Takanori
    Bekku, Kensuke
    Katayama, Satoshi
    Watanabe, Tomofumi
    Tsuboi, Ichiro
    Yoshinaga, Kasumi
    Maruyama, Yuki
    Yamanoi, Tomoaki
    Kawada, Tatsushi
    Tominaga, Yusuke
    Sadahira, Takuya
    Iwata, Takehiro
    Nishimura, Shingo
    Kusumi, Norihiro
    Edamura, Kohei
    Kobayashi, Tomoko
    Kurose, Kyohei
    Ichikawa, Takaharu
    Miyaji, Yoshiyuki
    Wada, Koichiro
    Kobayashi, Yasuyuki
    Araki, Motoo
    CLINICAL GENITOURINARY CANCER, 2024, 22 (04)
  • [5] The prognostic role of Gustave Roussy Immune Score (GRIm-Score) in metastatic lung adenocarcinoma patients treated with chemotherapy
    Soyler, Yasemin
    ozturk, Ayperi
    ANNALS OF CLINICAL AND ANALYTICAL MEDICINE, 2023, 14 (07): : 640 - 645
  • [6] Association between lung immune prognostic index and survival of patients with metastatic urothelial carcinoma treated with pembrolizumab
    Nakamura, Kazutaka
    Ishiyama, Yudai
    Nemoto, Yuki
    Ishihara, Hiroki
    Tachibana, Hidekazu
    Fukuda, Hironori
    Shinmura, Hiroaki
    Hashimoto, Yasunobu
    Yoshida, Kazuhiko
    Iizuka, Junpei
    Ishida, Hideki
    Kondo, Tsunenori
    Takagi, Toshio
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2023, 28 (07) : 913 - 921
  • [7] Association between lung immune prognostic index and survival of patients with metastatic urothelial carcinoma treated with pembrolizumab
    Kazutaka Nakamura
    Yudai Ishiyama
    Yuki Nemoto
    Hiroki Ishihara
    Hidekazu Tachibana
    Hironori Fukuda
    Hiroaki Shinmura
    Yasunobu Hashimoto
    Kazuhiko Yoshida
    Junpei Iizuka
    Hideki Ishida
    Tsunenori Kondo
    Toshio Takagi
    International Journal of Clinical Oncology, 2023, 28 : 913 - 921
  • [8] Association between comorbidities and survival in patients with metastatic urothelial carcinoma treated with pembrolizumab
    Hashimoto, Masaki
    Fukuokaya, Wataru
    Yanagisawa, Takafumi
    Yamamoto, Shutaro
    Koike, Yuhei
    Imai, Yu
    Iwatani, Kosuke
    Onuma, Hajime
    Ito, Kagenori
    Urabe, Fumihiko
    Tsuzuki, Shunsuke
    Kimura, Shoji
    Oyama, Yu
    Abe, Hirokazu
    Miki, Jun
    Kimura, Takahiro
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2024, 29 (05) : 612 - 619
  • [9] Association between comorbidities and survival in patients with metastatic urothelial carcinoma treated with pembrolizumab
    Masaki Hashimoto
    Wataru Fukuokaya
    Takafumi Yanagisawa
    Shutaro Yamamoto
    Yuhei Koike
    Yu Imai
    Kosuke Iwatani
    Hajime Onuma
    Kagenori Ito
    Fumihiko Urabe
    Shunsuke Tsuzuki
    Shoji Kimura
    Yu Oyama
    HIrokazu Abe
    Jun Miki
    Takahiro Kimura
    International Journal of Clinical Oncology, 2024, 29 : 612 - 619
  • [10] Evaluation of the prognostic importance of Gustave Roussy immune score in hepatocellular carcinoma patients
    Firat, Hatice Gulgun
    Onur, Ilknur Deliktas
    Camoz, Elif Sertesen
    Yildiz, Fatih
    JOURNAL OF HEPATOLOGY, 2024, 80 : S407 - S407
12345